BAYLOR COLLEGE OF MEDICINE
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 1900-10-30
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.bcm.edu
Effect of Vitamin D in Diets of Preterm Infants
Not Applicable
Active, not recruiting
- Conditions
- Premature Infants
- Interventions
- Dietary Supplement: PlaceboDietary Supplement: Vitamin D
- First Posted Date
- 2012-10-03
- Last Posted Date
- 2024-02-21
- Lead Sponsor
- Baylor College of Medicine
- Target Recruit Count
- 39
- Registration Number
- NCT01698840
- Locations
- 🇺🇸
Baylor College of Medicine / Texas Children's Hospital, Houston, Texas, United States
The Children in Action Feasibility Study
Not Applicable
Completed
- Conditions
- ObesityMotor Activity
- Interventions
- Behavioral: SPARK-EC
- First Posted Date
- 2012-10-02
- Last Posted Date
- 2012-10-02
- Lead Sponsor
- Baylor College of Medicine
- Target Recruit Count
- 274
- Registration Number
- NCT01697124
VA Home-Based Emotional Learning With Practical Skills
Not Applicable
Completed
- Conditions
- DepressionAnxiety
- Interventions
- Behavioral: CBT
- First Posted Date
- 2012-09-14
- Last Posted Date
- 2016-04-07
- Lead Sponsor
- Baylor College of Medicine
- Target Recruit Count
- 18
- Registration Number
- NCT01685528
- Locations
- 🇺🇸
Houston Center for Quality of Care and Utilization Studies, Houston, Texas, United States
Evaluation of Computer Generated After Visit Summaries
Phase 3
Completed
- Conditions
- Primary Care Patients With Chronic Conditions
- Interventions
- Other: Intermediate After Visit Summary ContentOther: Usual AVSOther: Minimum After Visit Summary ContentOther: Maximum After Visit Summary Content
- First Posted Date
- 2012-09-14
- Last Posted Date
- 2023-11-18
- Lead Sponsor
- Baylor College of Medicine
- Target Recruit Count
- 272
- Registration Number
- NCT01685541
A Pilot Study of Cabergoline for the Treatment of Cocaine Dependence
Phase 1
Completed
- Conditions
- Cocaine DependenceCocaine AbuseCocaine AddictionSubstance Abuse
- Interventions
- Drug: PlaceboDrug: Cabergoline
- First Posted Date
- 2012-07-27
- Last Posted Date
- 2012-07-27
- Lead Sponsor
- Baylor College of Medicine
- Target Recruit Count
- 11
- Registration Number
- NCT01651364
- Locations
- 🇺🇸
Michael E. DeBakey VA Medical Center, Houston, Texas, United States
Pramipexole as a Treatment for Cocaine Dependence
Phase 1
Completed
- Conditions
- Cocaine AbuseCocaine AddictionCocaine DependenceSubstance Abuse
- Interventions
- Drug: PlaceboDrug: Pramipexole
- First Posted Date
- 2012-07-27
- Last Posted Date
- 2014-07-22
- Lead Sponsor
- Baylor College of Medicine
- Target Recruit Count
- 10
- Registration Number
- NCT01651377
- Locations
- 🇺🇸
Michael E. DeBakey VA Medical Center, Houston, Texas, United States
Trial Comparing Duration of Analgesia After Popliteal Fossa Sciatiac Nerve Block With Ropivacaine 0.5% When Combined With Placebo, Dexamethasone 4mg or Dexamethasone 8 mg
Not Applicable
Withdrawn
- Conditions
- Pain, Sciatic Block
- Interventions
- Drug: PlaceboDrug: Dexamethasone 8 mgDrug: Dexamethasone 4 mg
- First Posted Date
- 2012-07-16
- Last Posted Date
- 2015-03-17
- Lead Sponsor
- Baylor College of Medicine
- Registration Number
- NCT01641419
- Locations
- 🇺🇸
Ben Taub General Hospital, Houston, Texas, United States
Nitric Oxide Flux and Ureagenesis in Argininosuccinate Synthetase Deficiency (ASSD)(Citrullinemia I)
Not Applicable
Completed
- Conditions
- Citrullinemia
- Interventions
- Other: stable isotope infusion
- First Posted Date
- 2012-06-01
- Last Posted Date
- 2015-03-20
- Lead Sponsor
- Baylor College of Medicine
- Target Recruit Count
- 6
- Registration Number
- NCT01610089
- Locations
- 🇺🇸
Baylor College of Medicine, Houston, Texas, United States
Treatment of B-CLL With Autologous IL2 and CD40 Ligand-Expressing Tumor Cells + Lenalidomide
Phase 1
Terminated
- Conditions
- B-cell Chronic Lymphocytic Leukemia
- Interventions
- Biological: B-CLL VaccineDrug: Lenalidomide
- First Posted Date
- 2012-05-23
- Last Posted Date
- 2016-02-08
- Lead Sponsor
- Baylor College of Medicine
- Target Recruit Count
- 2
- Registration Number
- NCT01604031
- Locations
- 🇺🇸
Houston Methodist Hospital, Houston, Texas, United States
Modafinil - Escitalopram Study for Cocaine Dependence
Phase 1
Completed
- Conditions
- Cocaine DependenceCocaine AbuseCocaine AddictionSubstance Abuse
- Interventions
- First Posted Date
- 2012-05-18
- Last Posted Date
- 2012-05-18
- Lead Sponsor
- Baylor College of Medicine
- Target Recruit Count
- 68
- Registration Number
- NCT01601730
- Locations
- 🇺🇸
Michael E. DeBakey VA Medical Center, Houston, Texas, United States
© Copyright 2025. All Rights Reserved by MedPath